As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Call for papers: Targeting cancer evolution in the clinic
The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.
Cord blood methylome in newborns and autism
Janine LaSalle and colleagues study the cord blood methylome in a high-familial risk cohort of autism spectrum disorder and identify a methylation signature at birth.
Special issue: Translating the microbiome
Our special issue on ‘Translating the microbiome in health and disease’, guest edited by Ramnik Xavier has launched. Check out new content added over the next months.
Best practices for variant calling
Daniel Koboldt discusses current best practices for variant calling in clinical sequencing studies, focusing on inherited disorders and cancer somatic mutation detection.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases
-
DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies
-
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era
-
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
Gut microbiome-host interactions in health and disease
-
Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
Focus: Immunology in Health and Disease
Read the latest papers on immunology across BMC flagship journals.
Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection
Daniel M. Muema et al.
Published in BMC Medicine 25 March 2020
The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
Shashuang Zhang et al.
Published in BMC Biology 17 March 2020
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus W. Löffler et al.
Published in Genome Medicine 30 April 2019
Host-associated microbiomes are predicted by immune system complexity and climate
Douglas C. Woodhams et al.
Published in Genome Biology 03 February 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
From the blog
-
-
World Diabetes Day 2020: nursing education and care
12 November 2020
-
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
2019 Journal Metrics
-
Citation Impact
10.675 - 2-year Impact Factor
10.637 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
